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Background: Observational research based on routine outcome monitoring is
prone to missing data, and outcomes can be biased due to selective inclusion at base-
line or selective attrition at posttest. As patients with complete data may not be rep-
resentative of all patients of a provider, missing data may bias results, especially when
missingness is not random but systematic.
Methods: The present study establishes clinical and demographic patient variables
relevant for representativeness of the outcome information. It applies strategies to
estimate sample selection bias (weighting by inclusion propensity) and selective attri-
tion bias (multiple imputation based on multilevel regression analysis) and estimates
the extent of their impact on an index of provider performance. The association
between estimated bias and response rate is also investigated.
Results: Provider‐based analyses showed that in current practice, the effect of
selective inclusion was minimal, but attrition had a more substantial effect, biasing
results in both directions: overstating and understating performance. For 22% of
the providers, attrition bias was estimated to be in excess of 0.05 ES. Bias was asso-
ciated with overall response rate (r = .50). When selective inclusion and attrition bring
providers' response below 50%, it is more likely that selection bias increased beyond
a critical level, and conclusions on the comparative performance of such providers
may be misleading.
Conclusions: Estimates of provider performance were biased by selection, espe-
cially by missing data at posttest. Results on the extent and direction of bias and min-
imal requirements for response rates to arrive at unbiased performance indicators are
discussed.
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Key Practitioner Message
Unbiased performance indicators require sufficient ROM
response rates.In the Netherlands, routine outcome monitoring (ROM) is implemented
to support individual treatments in mental health services (MHS) by
informing therapists and patients on the progress made (de Beurs
et al., 2011; Lambert, 2007). In addition, aggregated data from ROM
are used to evaluate and improve the quality of MHS (de Beurs,
Barendregt, & Warmerdam, 2017), in line with international efforts to
do the same (Kilbourne et al., 2018; Porter, Kaplan, & Frigo, 2017).
In 2006, performance appraisal became important when the Dutch
government introduced a new health insurance act for regulated com-
petition among providers and among health insurers (Enthoven & van
de Ven, 2007). Quality assessment is of key importance, as providers
are supposed to compete on quality and efficiency, insurers should
purchase care based on price and performance, and patients are
expected to make an informed choice for those providers with the
best outcomes. The new legislation aimed to counteract ever‐rising
health care costs and simultaneously improve quality by increasing
transparency about costs and outcomes.
The use of outcome data to monitor, evaluate, and learn from the
performance of mental health care providers is called benchmarking
(Bayney, 2005). A benchmarking institute, Stichting Benchmark
Geestelijke GezondheidsZorg (SBG, Foundation for Benchmarking
Mental Healthcare), was established as a trusted third party to inform
patients, providers, and insurers on the quality of health care (www.
akwaggz.nl). Treatment outcome was deemed the key performance
indicator, as “systematic outcomes measurement is the sine qua non
of value improvement” (Porter, Larsson, & Lee, 2016).
The nationwide implementation of routine assessment of treatment
outcomes in MHS started in 2010, with ROM serving multiple pur-
poses: as clinical support tool, as data source for performance appraisal
of providers for patients and financiers, and as data source for scientific
research. Assessments at regular intervals (e.g., every 3 months or even
session‐by‐session) are required to support treatment, but aggregated
pretest and posttest ROM data of treatments are adequate for perfor-
mance appraisal purposes (www.akwaggz.nl). Patients routinely com-
plete self‐report questionnaires on symptomatology in curative
outpatient care, and professionals complete rating scales on their
patients' functioning in care for severe mental illness. Providers send
their outcome data monthly to the benchmark institute, where data
are checked, aggregated, and transformed into various performance
indicators (de Beurs et al., 2016; de Beurs et al., 2017). Performance
of providers is evaluated by comparing the average pretest‐to‐posttest
change in symptoms, functioning, and health‐related quality of life for
various patient groups (common mental disorders, severe mental ill-
ness, geriatric psychiatry, and substance use disorders) achieved after
a year of treatment or after a completed treatment trajectory.
At the start in 2010, a 50% response rate was deemed achievable
based on estimates of 70% pretest and 70% posttest inclusion rates
(resulting in an overall 49% response rate). Also, we expected that at
least 50% response was required for valid aggregated outcome infor-
mation. This estimate was based on the literature (e.g., Livingston &Wislar, 2012) and on experiences with similar international endeavours,
such as the Minnesota Health Scores initiative (www.mnhealthscores.
org) and the pay‐for‐performance scheme of the English National
Health Service, where a response rate >50% is one of the requirements
for providers to qualify for a bonus payment (Gutacker, Street, Gomes,
& Bojke, 2015). Dutch MHS providers were allowed 5 years to achieve
this 50% response rate, with yearly increments of 10%, and their
response rates were monitored by SBG. ROM response rates rose
according to the plan. By 2016, 95% of all providers in the Netherlands
submitted data of concluded treatments to SBG monthly, and pretest
and posttest data of symptomatology and/or functioning were avail-
able for 47% of all treatments. There was substantial variance among
providers, with some achieving only 20% ROM response and others
reaching response rates of 90% or more (www.akwaggz.nl).
We aimed to investigatewhich factorsmay bias performance indica-
tors andwhich response rates yield sufficiently trustworthy information
on provider performance. Any response rate below 100% creates the
possibility of biased results, as patients with complete data may differ
systematically from nonresponders and may not be representative of
the entire population of the provider. A comprehensive body of litera-
ture has been published on missing data (Graham, 2009; Little & Rubin,
2014; Rubin, 2004; Seaman & White, 2011). Data can be Missing
Completely at Random (no relationship between whether a data point
is missing and any values within the data set, or any unobserved values).
More likely, data aremissing systematically, and here, two cases are dis-
tinguished: Missing at Random (there is a relationship between missing
data points and other observed values in the data set) and Missing Not
at Random (there is a relationship betweenmissingness and unobserved
data). The latter is nonignorable, as it will bias results (Graham, 2009). An
example is endogenous selection bias (i.e., conditioning on a collider;
Elwert & Winship, 2014). For instance, some patients may be harder
to assess and more difficult to treat too. Consequently, the measured
outcomes from more easily assessed patients would overestimate the
benefits of MHS treatment, would not be an accurate reflection of the
true nationwide results, or would not reflect the true performance of a
single MHS provider. Minimization of selection bias or at least informa-
tion on the extent of bias per provider is essential for the validity and
utility of the performance indicator. How much the results are biased
depends on the extent of systematic differences between patients with
complete and incomplete data. The extent of bias may also depend on
the response rate of a provider (Gomes, Gutacker, Bojke, & Street,
2015; Hoenders et al., 2014; Young, Grusky, Jordan, & Belin, 2000).
The present study sets out to investigate these issues.
With longitudinal treatment outcome data, selection (accidently or
intentionally) can occur at two time points: pretest and posttest.
Omission of pretest data may lead to selective inclusion bias; omission
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432 DE BEURS E. ET AL.of posttest data from included subjects may cause selective attrition
bias. Through selective inclusion at pretest, performance indicators
of providers will become positively biased when predominantly
patients are assessed for whom a good outcome is expected (e.g.,
well‐treatable patients with less complex problems, little co‐morbid
psychopathology or co‐morbid somatic problems, a first episode,
employed, extensive social network, and high socio‐economic status
[SES]). Conversely, performance indicators will become negatively
biased when mostly difficult‐to‐treat patients are included. An investi-
gation of sample selection bias in ROM data should therefore focus on
patient variables with prognostic value for outcome. Selective attrition
at posttest will bias outcome towards the positive when patients with
unsuccessful therapies are not reassessed. Such bias can be intention-
ally introduced in the data collection phase but can also occur uninten-
tionally, for instance, because unsuccessfully treated patients (e.g.,
early dropouts) are less compliant with a posttest assessment.
Intentional or not, we cannot assume that inclusion or attrition
occur at random: patients with complete data may differ from the
noncomplete group, and countrywide results and findings on the per-
formance of individual providers may become biased by selection.
Both inclusion and attrition bias threaten the external validity of the
results (Cuddeback, Wilson, Orme, & Combs‐Orme, 2004). Further-
more, the lower the response rate obtained by an MHS provider, the
more room there is for biased results.
We investigated the association between patient characteristics
(demographic and clinical) and outcome, their association with inclu-
sion and attrition, and their potential to bias aggregated outcomes of
providers. Hence, for each provider, we established (a) bias due to
selective inclusion at pretest, (b) bias due to selective attrition at post-
test, and (c) the combined biasing effect of inclusion and attrition. We
also investigated the association between naturally occurring ROM
response rates and extent of bias. Based on the findings, we will dis-
cuss minimal requirements for inclusion, attrition, and overall response











Abbreviations: GAF, Global Assessment of Functioning; SES, socio‐eco-
nomic status.2 | METHODS
2.1 | Patient, treatments, and providers
The present study is limited to treatments concluded in 2016 of adult
outpatients (aged 18–65) predominantly with common mental disor-
ders, such as mood and anxiety disorders of mild to moderate severity.
Other groups of patients were included in this nationwide effort
(severe mental disorders, elderly patients, and substance abuse) but
different outcomes (and instruments) were used, so these groups are
omitted from the present analysis. Mean age of the present sample
was X
_
= 38.30 (SD = 13.50); 61.1% was female; and 31.9% was treated
for depression, 24.5% for an anxiety disorder, and 16.8% for a person-
ality disorder (see Table 1).
Treatments were pharmacological, psychosocial (e.g., cognitive–
behavioural therapy), or a combination of both, predominantly pro-
vided in individual weekly or biweekly sessions with a psychiatrist,clinical psychologist, or psychiatric nurse, as well as in group format.
The present study is limited to the first year of treatment; the average
duration of treatments was M = 42.2; SD = 13.4; range = 1–52 weeks.
Providers can be large nationwide‐operating institutions, large
institutions providing integrated MHS in a specific region of the
DE BEURS E. ET AL. 433country, smaller institutions working locally, or even private practi-
tioners. SBG has contracts with 500+ institutional providers. For the
present study, only data were used from institutional providers who
submitted at least 25 treatments with complete pre–post data per pro-
vider to arrive at a reliable estimate of their performance. This resulted
in n = 113,707 treatments and n = 135 providers. Data of small institu-
tional providers were thus excluded. Individual providers working in
private practice were not included in the current data set either.
2.2 | Demographic and clinical patient variables
Demographic variables included age, gender, living situation, educa-
tional level, urbanization level, and SES, the last three variables each
in five levels. Clinical variables included pretest T‐score, Global
Assessment of Functioning (GAF) score, and primary diagnosis coded
according to the Dutch reimbursement system for Diagnosis‐
Treatment Combinations, which follows the taxonomy of the
Diagnostic and Statistical Manual of Mental disorders ‐ 4th edition
(DSM‐IV) (American Psychiatric Association, 2000).
2.3 | Treatment outcome
To assess severity of symptomatology with common mental disorders,
generic self‐report measures were used such as the Brief Symptom
Inventory (Derogatis, 1975), the Outcome Questionnaire‐45 (Lambert,
Gregersen, & Burlingame, 2004), and the Symptoms Questionnaire‐48
(Carlier et al., 2012). Scores on these self‐report questionnaires were
transformed into a common metric (normalized T‐score) with a pretest
mean of T = 50 (SD = 10). Treatment outcome was operationalized as
the pretest‐to‐posttest difference in severity of symptoms expressed
in T‐scores (ΔT), achieved within the first year of treatment. The aver-
age outcome was ΔT = 7.29; SD = 10.17.
2.4 | Threshold values for selective inclusion bias
and attrition bias
For selective inclusion or attrition bias, a critical cut‐off value was set
at 0.50 ΔT points. As ΔT is based on T‐scores with SDpretest = 10, a
0.50 ΔT‐point implies a 0.05 shift in standardized pre–post difference
or an effect size of ES = 0.05 (Cohen, 1988; Seidel, Miller, & Chow,
2013). A critical cut‐off value of 0.50 implies that we deem a differ-
ence between two providers larger than 1.0 points as not attributable
to inclusion or attrition bias.
2.5 | Statistical analysis
2.5.1 | Patient predictors of outcome
Wehad previously established the prognostic value for posttest level of
symptoms in a more extensive set of clinical and demographic variables
(Iezzoni, 2013; Warmerdam, de Beurs, Barendregt, & Twisk, 2018),
using nonmissing data of the entire sample (n = 59,136). Administrative
data, irrespective of whether a pretest or a posttest ROM assessmenthad taken place, were available for almost all patients (95.1%). Only sta-
tistically significant demographic and clinical predictors with substan-
tive prognostic power were selected and re‐evaluated as predictors, as
variables without influence on outcome are unlikely to bias the perfor-
mance indicator. The selected variables were analysed with multilevel
multivariate regression analysis, incorporating the provider as a level.
Inclusion bias was assessed by comparing demographic and clinical
characteristics of patients with and without a pretest score on the out-
come measure. We calculated weighted outcome (had all patients
been included) by inverse probability weighting (Austin & Stuart,
2015; Rubin, 1997; Seaman & White, 2011). Probability of inclusion
was based on multilevel logistic regression analysis, also including
the provider as a level in the model. Subsequently, each case got a
weight inversely proportional to their chance of inclusion. For
example, if personality disorders are underrepresented in the inclusion
sample (the subsample with pretest data), all patients with a personal-
ity disorder get a weight >1.00 in the analysis. Cases with missing
values on the predictors (4.9% of the entire sample) were given a
weight of 1.00. Inclusion bias was established by comparing actual
pretest‐to‐posttest change (ΔT), with estimated change after
weighting of cases based on the inverse of the propensity score for
inclusion. The estimated change score is reported as ΔTweighted.
To estimate attrition bias, missing posttest data were imputed with
an estimation of their value based on the pretest score, other prognos-
tic patient characteristics, and provider performance (multilevel
imputation; Díaz‐Ordaz, Kenward, Cohen, Coleman, & Eldridge,
2014). To preserve variance in the outcome scores, imputation was
repeated five times and the pooled results are reported as ΔTimputed
(multiple imputation). Lastly, we combined both sources of bias by
estimating outcome after propensity‐of‐inclusion weighting was
applied to the data set where missing posttest scores had been
imputed (ΔTcombined).
The extent of bias in the nationwide results and per provider was
established by subtracting the ΔTs after propensity weighting of
included cases (ΔTweighted), imputation of missing posttest data
(ΔTimputed), and the combined effect of propensity weighting and impu-
tation (ΔTcombined) from the original ΔT. Positive bias implies overstated
results. The association between response rates and extent of inclusion
bias, attrition bias, and combined bias is graphically presented in
scatterplots and assessed with Pearson correlation coefficients.3 | RESULTS
Figure 1 presents the loss of data in the present data set due to non-
response in a flowchart. Data were available from N = 113,707 treat-
ments, showing that 25,818 cases were compared with 87,889 cases
with pretest data to assess selective inclusion and 59,136 cases were
compared with 28,753 cases to assess selective attrition.
To select relevant patient characteristics, we first analysed the
bivariate association between demographic and clinical patient vari-
ables (predictors) and the posttest score. Most variables had a statisti-
cally significant association with outcome, but only five contributed
FIGURE 1 Flowchart for inclusion and attrition of individual patients
TABLE 2 Association of demographic and clinical pretest data with
posttest symptomatology based on multilevel analysis
Predictor β SE 95% CI η2
Pretest T‐score .601* 0.004 [0.593, 0.608] .311
GAF −.143* 0.005 [−0.153, −0.130] .062
SES −.297* 0.028 [−0.353, −0.241] .003
Age .029* 0.003 [0.023, 0.035] .001
Urbanization −.161 0.034 [−0.228, −0.095] .000
Gender −.426 0.080 [−0.584, −0.270] .000
Diagnoses
Personality 1.600* 0.551 [0.520, 2.681] .011
Mood −.562 0.547 [−1.634, −0.511] .000
Anxiety −.161 0.548 [−1.237, −0.915] .000
Developmental −.183 0.554 [−1.270, −0.904] .000
Somatoform −.741 0.566 [−1.459, −0.759] .000
Eating −.116 0.587 [−1.005, 1.296] .000
Other −.908 0.574 [−2.033, 0.216] .000
Abbreviations: GAF, Global Assessment of Functioning; SES, socio‐eco-
nomic status.
*β significant at p < .0001.
TABLE 3 Association of demographic and clinical pretest data with
inclusion and attrition (multilevel logistic regression analyses)
Predictor
Pretest inclusion
β SE p OR 95% CI
Personality .017 0.020 .380 1.017 [0.850, 1.010]
SES .049 0.010 .000 1.050 [1.045, 1.055]
GAF .018 0.001 .000 1.018 [1.017, 1.020]
Age −.001 0.001 .044 0.999 [0.998, 1.000]
Posttest attrition
β SE p OR 95% CI
Personality .073 0.020 .000 1.076 [1.036, 1.116]
SES .042 0.005 .000 1.043 [1.010, 1.090]
GAF .011 0.001 .000 1.011 [1.009, 1.013]
Age .007 0.001 .000 1.007 [1.006, 1.009]
Pretest T‐score −.001 0.001 .372 0.999 [0.998, 1.000]
Abbreviations: GAF, Global Assessment of Functioning; SES, socio‐eco-
nomic status.
434 DE BEURS E. ET AL.substantially to the multiple model (partial η2 > .001, seeTable 2). More
severe symptomatology (a higher pretest T‐score) and worse function-
ing (lower GAF score) have the most influence on the posttest score.
The five predictors with substantial prognostic value for outcome of
Table 2 were used to assess selective inclusion and selective attrition in
two multiple multilevel logistic regression analyses with binary depen-
dent variables (“included at pretest or not” and “assessed at posttest
or not”). Table 3 presents the results. The combination of three prog-
nostic variables predicted inclusion significantly: χ2(5) = 1,053.88;
p < .001. Better functioning (higher GAF score) at pretest, higher SES,
and lower age were associated with being included at pretest. These
three variables were used to calculate the propensity score.
Having a personality disorder, higher SES, better functioning
(higher GAF score), and higher age were associated with attrition atposttest; the pretest T‐score (the most prominent predictor of the
posttest score) was not associated with attrition. The combination of
the four variables predicted attrition significantly: χ2(6) = 656.45;
p < .001. These four variables and the pretest score (all variables that
appeared predictive of outcome in Table 2) were used to estimate
missing posttest scores for imputation. The multilevel estimation of
propensity and imputation included one additional level: the provider.3.1 | Analysis of patient‐based data
Next, mean ΔT before and after imputation and before and after
inverse propensity weighting was established. On the Per patient col-
umns, Table 4 presents the average ΔT score for n = 59,136 cases with
complete data (ΔT), after weighting cases based on the inverse propen-
sity score for inclusion (ΔTweighted), after imputation of missing posttest
scores (ΔTimputed), and after both weighting and imputation of missing
posttest scores (ΔTcombined). Overall, weighting has a greater effect on
the average ΔT than imputing missing posttest scores. Weighting of
cases affects the mean ΔT substantially: ΔTweighted is 0.95 points higher
than ΔT was, indicating that the original ΔT was a slight underestima-
tion. Attrition bias was smaller and in the other direction: ΔTimputed is
only 0.11 points lower than the originally achieved ΔT. The combined
effect of inclusion and attrition bias is 0.77 points. This suggest that
the results based on incomplete data slightly underestimate the true
treatment outcome for the average patient.3.2 | Analysis of provider‐based data
At least 25 treatments with complete data were submitted by 135
providers. The largest provider contributed 10,303 cases, the smallest
25. The median number of treatments was M = 141. We assessed
TABLE 4 Results of patient‐based and provider‐based analyses of data, demonstrating the extent of bias in average ΔTs
Performance
indicator






ΔT 59,136 7.29 10.17 7.19 2.73 −0.62 15.34
ΔTweighted 113,707 8.24 10.39 7.18 2.72 −0.55 15.19
ΔTimputed 87,889 7.18 10.20 7.16 2.59 −0.05 14.69
ΔTcombined 113,707 8.06 10.39 7.17 2.57 −0.10 14.64
Abbreviations: ΔT, difference between pretest and posttest T‐score; ΔTcombined, difference between pretest and posttest after imputation of missing post-
test scores and inverse propensity weighting; ΔTimputed, difference between pretest and posttest after imputation of missing posttest scores; ΔTweighted,
difference between pretest and posttest adjusted by inverse propensity weighting.
DE BEURS E. ET AL. 435selective inclusion and attrition bias per provider and calculated the
mean ΔT of all providers, based on their average performance.
Selection was substantial: the mean percentage of included
patients at pretest was 77% (range among providers: 19–99%). How-
ever, selective inclusion did not bias the average outcome substan-
tially (see Table 4, Per provider columns).
There was considerable attrition too. The mean percentage of
included patients who were reassessed after 1 year was 66% (range
among providers: 25–92%), but again, this did not bias the overall
mean performance of all providers. The overall response rate after
selection due to inclusion and attrition was 52% (range 11–90%).
All differences between the various mean ΔTs on the Per patient
columns of Table 4 are small and not statistically significant
(T < 0.95; p > .34), and the countrywide provider‐based average is
not affected by selection bias.3.3 | Bias per provider
Bias due to selective inclusion ranged from −0.53 to 0.49 among pro-
viders: only one provider had a bias of ±0.50 or more, and 10 pro-
viders (7.4%) had a bias of ±0.25 or more (see Table 5 and Figure 2).
There was no relation between the percentage of included patients
and absolute inclusion bias (r = −.10, n = 135, p = .27). Bias due to
attrition ranged from −1.44 to 1.25 among providers: 30 providers
(22.2%) had a bias of ±0.50 or more, and 15 providers (11.1%) had a
bias of ±0.70 or more. The association between the percentage of
missing posttests and absolute attrition bias was substantial: r = .48,
n = 135, p < .001. Bias due to the combined effect of inclusion andTABLE 5 Number (%) of providers with inclusion, attrition, and
combined bias beyond set limits
Biasa
Absolute bias
Criterion ≤−.50 ≥.50 ≥.50
Inclusion 1 (0.7) 0 (0.0) 1 (0.7)
Attrition 13 (9.6) 17 (12.6) 30 (22.2)
Combined 13 (9.6) 16 (11.9) 29 (21.5)
aBias calculated as ΔT minus ΔTweighted, ΔT imputed, or ΔT combined; positive
bias implies overstated results.attrition ranged from −1.53 to 1.25 among providers: 29 providers
(21.5%) had a bias of ±0.50, and 13 providers (9.6%) had a bias
±0.70. There was again a strong association between overall response
and absolute bias: r = .50, n = 135, p < .001. Bias went both ways: 16
providers had positively biased results (ΔT > ΔTcombined), and 13 pro-
viders had negatively biased results (ΔT > ΔTcombined).4 | DISCUSSION
In this paper, we presented a strategy to estimate both inclusion and
attrition bias in ROM data to assess provider performance. Included
and nonincluded patients at pretest did not differ on most demo-
graphic and clinical variables. Although some statistically significant
differences were found, the size of their effect (bivariate and multiple)
on outcome was small and close to zero. Nevertheless, in the patient‐
based analyses, selection bias was found, predominantly due to selec-
tive inclusion. Also, selective attrition at posttest biased the results,
here most visibly in the results of provider‐based analyses. These find-
ings stress the value of distinguishing both sources of bias: selective
inclusion and selective attrition. Finally, the results reveal that an over-
all response rate of 50% adequately safeguards against biased
provider‐based results.
When analysing patient‐based data, the nationwide average was
more biased by selective inclusion than by attrition. The elevated
ΔTweighted is most likely due to giving more weight to cases with a
lower level of functioning (GAF scores are negatively associated with
pre–post gain). However, the biasing effect of selective inclusion
was less pronounced when inspecting the results per provider.
Provider‐based data also demonstrated effect of selection, but bias
went in both directions, with half of the providers increasing their
ΔT and the other half decreasing it. Apparently, the two effects even
each other out in the provider‐based nationwide average. These find-
ings taken together suggest that selective inclusion is potentially a
strong biasing factor, but institutes do not appear to selectively
include patients in ROM. For only one provider, statistical correction
for selective inclusion led to a substantially lower ΔT (bias > −.50);
for all other providers, inclusion bias remained within critical limits.
Finally, there is no association between inclusion rate and bias; a low
inclusion rate does not appear to lead to biased results. These findings
FIGURE 2 Scatterplots of bias due to selective inclusion, selective attrition, and bias due to all combined by response percentage. Points
represent the response rate of providers (x‐axis) by the extent of the bias (y‐axis) in ΔT units; positive bias implies overstated results, negative
bias understated results
436 DE BEURS E. ET AL.seem contradictory but may be explained by providers' current moti-
vation to optimize inclusion rates through incentives from their finan-
ciers. No financing of MHS based on outcomes has been implemented
yet in the Netherlands. Consequently, providers are motivated to
assess as many patients as possible rather than exclude potentially
hard‐to‐treat patients from pretest assessment and thus keep unsuc-
cessful treatments out of view. Hence, although selective inclusion
can potentially bias outcome results strongly, it appears to be a factor
with only limited effect in current performance monitoring among pro-
viders in the Netherlands.
The patient‐based analysis on selective attrition at posttest
showed that imputation of missing data had only a limited effect on
the countrywide average, but a provider‐based analysis revealed
biased results for n = 30 providers (22.2%) due to selective attrition.
Moreover, a strong association is found between the extent of post-
test attrition and absolute bias. As previously mentioned, providers
are incentivized for response rates and not for outcomes. Conse-
quently, attrition is most likely due to unwillingness of patients to
comply with reassessments when their treatment was unsuccessful
rather than a result of intentionally not assessing unsuccessful treat-
ments at posttest. For instance, a substantial proportion of patients
terminate their treatment at an early stage, usually after one or two
sessions (Swift & Greenberg, 2012), and it is difficult to obtain posttest
data from these patients.
Statistical correction for both selective sampling mechanisms, by
weighting cases based on their propensity for inclusion and by imput-
ing posttest scores, exposed 29 providers with biased results. Interest-
ingly, bias went both ways, with some providers having better
outcomes after statistical correction (n = 16, 11.9%) and some having
worse outcomes (n = 13, 9.6%). Some providers may selectively
include patients who are more likely to have a positive outcome or
selectively leave failed treatments unassessed, leading to a positively
biased outcome indicator. Interestingly, a similar proportion of pro-
viders had negatively biased results, possibly due to overinclusion of
hard‐to‐treat patients or a selective overrepresentation at posttest
of failed treatments. The present data were collected in a context
where providers were incentivized to obtain high response rates.
Results may be different if providers are incentivized towards betterperformance, for example, by a pay‐for‐performance scheme. This
may encourage exclusion of hard‐to‐treat cases at pretest and exclu-
sion of failed treatments at posttest, resulting in biased performance
indicators and exaggerating what has been achieved in treatment.
With the present data‐analytic approach, we can reveal the extent
of this bias and flag overstated performance.
Close inspection of Figure 2 reveals that the extent of inclusion
bias was limited; for most providers, bias due to selective inclusion fell
between critical limits of ±0.50. Attrition had a more profound biasing
effect, and a minimum 70% response is required to keep bias within
critical limits. When both effects are combined, the graph suggests
that at least 50% response is required to keep bias sufficiently at
bay. When a 50% response rate was achieved, only four providers
(3.0%) remained biased due to the combined effect of selective inclu-
sion and attrition beyond the stringent limit of 0.5 ΔT points. How-
ever, it should be noted that currently, only 62 (45.9%) of the
providers achieve this level of completeness of data.
The present findings suggest that 100% implementation of ROM is
not needed to obtain valid information on providers' performance, as
weighting for noninclusion and imputation of missing posttest scores
yields similar results for most providers on the performance indicator.
A posttest inclusion rate of 70% and an overall response rate of at
least 50% seems sufficient for a representative estimate of a pro-
vider's performance. This 50% response rate coincides with required
levels of the pay‐for‐performance scheme of the British National
Health Service (Gutacker et al., 2015). For providers with a response
rate under 50%, results on their performance became untrustworthy,
as chances are that their results were more than 0.5 ΔT points off
the mark. The lower the overall response rate, the larger the bias
and the more bias went both ways: some providers scored higher
and some lower after correcting for selection bias.
The findings support the initial decision from 2010 to recommend
50% response as a minimum requirement for providers, in order to
deem their results sufficiently unbiased by selection. There are other
reasons to strive for optimum implementation of ROM beyond the
50% mark and to encourage providers to improve data collection. First
of all, ROM was not primarily implemented for accountability but pre-
dominantly intended as a beneficial adjunct to treatment (de Beurs,
DE BEURS E. ET AL. 437Barendregt, & Warmerdam, 2017). Research has shown that ROM by
itself can lead to better results (Boswell, Kraus, Miller, & Lambert,
2013), especially for patients at risk for treatment failure (Lambert,
2010). Treatment failures tend to be overlooked by therapists
(Hannan et al., 2005). ROM can also lead to more efficient treatment
delivery as outcome feedback may reduce treatment length (Delgadillo
et al., 2017). Furthermore, ROM grants patients a more active role in
their own recovery (Patel, Bakken, & Ruland, 2008). All patients
deserve this adjunct to treatment, not merely a fraction to ensure a
nonbiased performance indicator. Hence, striving for high ROM
response rates is good clinical practice, but it is also vital to counteract
providers who game the system (Bevan & Hood, 2006) by biasing
results through deliberate pretest or posttest selection of treatments
with actual or expected positive outcomes.
The general aim of ROM and benchmarking (continuous improve-
ment of MHS quality) is underwritten by all stakeholders, but
benchmarking is still a controversial element, especially for those
who fear negative financial consequences. Opponents criticize the
validity or value of performance indicators based on ROM (van Os
et al., 2012) and echo warnings for perverse consequences, such as
cherry‐picking the best treatable patients (Killaspy, 2018) or gaming
the system by other means (Jacobs, 2014). Others warn of adverse
effects on the clinical application of ROM if data are also used for
benchmarking (Delespaul, 2015). Indeed, some Dutch providers have
implemented a minimal variant of ROM, measuring only at pretest
and posttest, which enables submitting data to SBG but does not sup-
port clinical decision making during treatment. The controversy
regarding the various ambitions with ROM resulted in a heated debate
in the Netherlands, and selection bias is only one threat to the validity
of benchmarking data and other issues are still unresolved. Thus, the
discussion is ongoing about the usefulness of gathering nationwide
outcome data, focusing on patients' privacy and the suitability of out-
come data to serve as a quality indicator of treatment. Currently, a
new foundation (Stichting Akwa GGZ) is charged with finding a better
balance between these two aims and will revise the system to increase
its usefulness to plan, monitor, and modify individual treatment. The
selection of allowed outcome measures will be broadened to include
disorder‐specific measures, and guidelines for the frequency of ROM
assessments will be offered. Patients will be asked to explicitly con-
sent to the use of their ROM data for quality monitoring. Publication
of providers' aggregated outcomes will become voluntary and depend
on their contract with insurers.4.1 | Strengths
There are various approaches to imputation of missing posttest data to
choose from (Díaz‐Ordaz et al., 2014), depending on whether differen-
tial provider effects are taken into account (Taljaard, Donner, & Klar,
2008) or not: multiple (single‐level) regression analysis and multilevel
regression analysis. Multiple regression estimation of missing posttest
scores is based on pretest information on demographic and clinical
characteristics of patients. Basically, missing posttest data areestimated on what is achieved on average with other patients with sim-
ilar characteristics. However, this estimate does not take into account
the performance of the provider. By contrast, imputation based on
multilevel analysis does consider provider performance (based on com-
plete pretest‐to‐posttest data). Consequently, the single‐level
regression‐based approach diminishes differences between providers,
whereas the multilevel approach takes these differences into account.
As there is considerable variation in outcomes among providers, the
multilevel approach was deemed the most appropriate, even though
the more stringent approach yielded a verdict of biased results more
readily. It is nonetheless wise to set the bar high for validity of perfor-
mance indicators and better to err on the side of deeming them biased
rather than too readily deeming them valid.
It is not uncommon to assess selection bias by comparing subjects
with complete data to all other subjects with incomplete data, irrespec-
tive of when data loss occurred (Gomes et al., 2015). However, in a lon-
gitudinal study design, data loss can occur at two distinct time points:
the pretest and the posttest. In the present study, selection bias was
divided into two potential sources of bias: selective inclusion and selec-
tive attrition, and effects of both were investigated separately. Differ-
ent variables were associated with loss of data at pretest and at
posttest. According to patient‐based analyses, selective inclusion had
a greater biasing effect than selective attrition. This is a fortunate find-
ing because it is easier for a provider to counteract data loss at pretest
than at posttest. At pretest, most patients are willing to meet demands
for information on the severity of their illness or other variables. At
posttest, it may be more difficult to obtain this information, especially
from patients who discontinue treatment prematurely. This may limit
the window of opportunity to get such data. Consequently, bias due
to attrition is harder to prevent than bias due to selection.
This paper offers a strategy for providers who want to know the
trustworthiness of their aggregated ROM data and want to establish
whether their outcomes are biased by selective inclusion or attrition.
Multiple imputation and weighting will give a methodologically sound
estimate of the extent and direction of potential bias, even though
multilevel analysis is not feasible with data from a single provider.
However, the underlying analyses may be too complicated or cumber-
some for many providers. For them, the present results do offer a sim-
ple message: ensure that you have a high response rate (>50%) and the
risk of biased results will be limited.When the response rate falls below
50%, ΔT might be biased and misleading as performance indicator.4.2 | Limitations
A limitation of this study is that we restricted our sample to adult
patients with common mental disorders. Findings may be different for
other age groups or disorder groups, and this still needs to be investi-
gated. For instance, with severe mental disorders, we assess treatment
outcome with the HoNOS (Wing et al., 1998), a rating scale usually
completed by a professional. Then, the professional, not the patient,
is the source of the data, and consequently nonresponse is due to lack
of compliance of professionals with administrative processes, like
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missingness may be even more likely. Furthermore, in the Netherlands,
treatment outcome is evaluated at least once a year, and for the present
study, we used outcome data from the first year of treatment. This
means that longer treatment trajectories were only partially evaluated.
Weighting and imputation of posttest data was based on a selec-
tive set of demographic and clinical variables. Various other factors
such as work status or ethnic background may be relevant, but these
data were not available to us. Further research should include addi-
tional factors that are potentially associated with outcome and
missingness of outcome data. In addition, interactions between
observed demographic and clinical variables may be relevant to out-
come. For instance, the effect of age or gender may differ between
diagnostic groups. Interactions among predictors were not included
in the present study, as they would complicate a subject that is already
difficult to understand.
To assess selective inclusion, an alternative approach to inverse
probability weighting would have been multiple imputation of missing
data. Based on patient characteristics, a pretest score could have been
estimated and imputed as well. Based on this imputed pretest score
and other patient characteristics, a posttest score can be estimated
and imputed. We decided against this double imputation, as it would
have multiplied the uncertainty about the resulting score and ΔT.
We do not know of studies where this double imputation process
has been applied and evaluated.5 | CONCLUSION AND IMPLICATION
If response rates fall below 50%, there is a substantial chance of
aggregated outcomes of providers being biased by selective inclusion
or attrition. We propose using two extra indicators per provider for
the trustworthiness of their performance indicator: the overall
response rate (>50% or not) and whether the results are unbiased by
the combination of selective inclusion and attrition (<0.5 ΔT differ-
ence or <0.05 ES between weighted posttest imputed performance
and observed performance). Accordingly, the representativeness of
the outcome data will be adequately revealed.
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